Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America
|
May 3, 2017
Enantiomerically enriched, polycrystalline molecular sieves
Stephen K Brand, Joel E Schmidt, Michael W Deem, et al.
Chemistry of Materials : a Publication of the American Chemical Society
|
December 31, 2025
Lessons from Failed Attempts of Computationally Guided Synthesis of Aluminosilicate STF and IFR Zeolites in Hydroxide Media
Omer F Altundal, Maria Galvez-Llompart, Angel Cantin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2016
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models
Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
Investigational New Drugs
|
November 5, 2016
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies
Alexandra Tyulyandina, Daniel Harrison, Wei Yin, et al.
Drugs in R&D
|
September 11, 2004
Correlations between factors determining the pharmacokinetics and antiviral activity of HIV-1 non-nucleoside reverse transcriptase inhibitors of the diaryltriazine and diarylpyrimidine classes of compounds
Paul Lewi, Eddy Arnold, Koen Andries, et al.
Journal of Computer-Aided Molecular Design
|
September 19, 2003
On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data
Paul J Lewi, Marc de Jonge, Frits Daeyaert, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)
Paul A J Janssen, Paul J Lewi, Eddy Arnold, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America
|
May 3, 2017
Enantiomerically enriched, polycrystalline molecular sieves
Stephen K Brand, Joel E Schmidt, Michael W Deem, et al.
Chemistry of Materials : a Publication of the American Chemical Society
|
December 31, 2025
Lessons from Failed Attempts of Computationally Guided Synthesis of Aluminosilicate STF and IFR Zeolites in Hydroxide Media
Omer F Altundal, Maria Galvez-Llompart, Angel Cantin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 3, 2016
Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models
Ilya Tsimafeyeu, John Ludes-Meyers, Evgenia Stepanova, et al.
Investigational New Drugs
|
November 5, 2016
Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies
Alexandra Tyulyandina, Daniel Harrison, Wei Yin, et al.
Drugs in R&D
|
September 11, 2004
Correlations between factors determining the pharmacokinetics and antiviral activity of HIV-1 non-nucleoside reverse transcriptase inhibitors of the diaryltriazine and diarylpyrimidine classes of compounds
Paul Lewi, Eddy Arnold, Koen Andries, et al.
Journal of Computer-Aided Molecular Design
|
September 19, 2003
On the detection of multiple-binding modes of ligands to proteins, from biological, structural, and modeling data
Paul J Lewi, Marc de Jonge, Frits Daeyaert, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine)
Paul A J Janssen, Paul J Lewi, Eddy Arnold, et al.
Page
of 2